Skip to main content
. 2022 Mar 23;12:832228. doi: 10.3389/fonc.2022.832228

Table 1.

Summary of cases of DIE malignant transformation.

Reference Age Clinical presentation Invasion site Surgery Pathological type Adjuvant therapy Outcome
Yang et al. (9) 57 vaginal bleeding, left lower abdominal pain Douglas cul-de-sac RAU + BAR + LE + OE + AE + PRR + OS EC CT DFS: 12 mo
Marchand et al. (14) 63 pelvic discomfort, abdominal distension rectovaginal septum TR + UTER + BAR + LE + OE EC DFS:18 mo
Kim et al. (15) 40 No rectovaginal septum TR + RAU + PRR EC HRT DFS: 8 mo
Ota et al. (16) 48 pelvic pain Uterosacral ligament UTER + OE + LE+ EC CT DFS: 2 yr
Mabrouk et al. (17) 36 abdominal discomfort rectovaginal septum RAU + LE + OE + AE + PRR + OS EC CT DFS: 2 mo
Verma et al. (18) 49 sudden onset abdominal pain Caecum radical right hemicolectomy EC No Loss of follow-up
Kondo et al. (19) 52 genital bleeding vaginal No CCC CT R: 11 yr (Surgery: CCC)
Tarumi et al. (20) 45 frequent urination and miction pain bladder UTER partial bladder resection EC CT DFS: 10 mo

RAU, Radical uterectomy; BAR, Bilateral adnexal resection; UAR, Unilateral adnexal resection; LE, Lymphadenectomy; UTER, Uterectomy; PRR, partial rectal resection; OS, ostomy; OE, Omentectomy; TR, Tumor resection; AE, Appendectomy; RT, Radiotherapy; CT, Chemotherapy; HRT, Hormone therapy; CRT, Chemo-and radio-therapy; DFS, Disease free survival; DOD, Dead of disease; LWD, Living with disease; R, Recurrence; EC, Endometrioid adenocarcinoma; CCC, clear-cell carcinoma.